# Env-specific antibodies promote post-treatment control in SIV-infected macaques

Source: [nature.com](https://www.nature.com/articles/s41564-026-02426-z) · 2026-11-10 · Life
Page: https://themorning.science/story/env-specific-antibodies-promote-post-treatment-control-in-siv-infected-macaques-8787bb6e57d0bacf
Kind: research · Impact: medium

## In brief

- A Nature Microbiology study, published online 10 November 2026, examines Env-specific antibodies and post-treatment control in SIV-infected macaques.
- The source reports that combining antiretroviral therapy, CD8α lymphocyte depletion and N-803 in SIV-infected rhesus macaques achieved latency reversal but not reservoir reduction.
- Only the article abstract snippet was available, so the study's full methods and results are not covered here.

## Why it matters

The study addresses post-treatment control and the viral reservoir in SIV-infected macaques, a model used in HIV cure research. Its finding that latency reversal did not reduce the reservoir is relevant to researchers designing cure strategies.

## Timeline

- 2026-11-10: Study published online in Nature Microbiology

## Coverage

- [Env-specific antibodies promote post-treatment control in SIV-infected macaques](https://www.nature.com/articles/s41564-026-02426-z) — nature.com, 2026-11-10

Tags: hiv, siv, antibodies, latency reversal, hiv reservoir, macaques

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science